BAKER BROS. ADVISORS LP – Akero Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$80.64M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+260.32%
quarter
Akero Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1900.69% | 2.25M shares | 79.52M | $34.05 | 2.36M |
| Q2 2022 | share | 0.00% | 0 shares | -561K | $9.45 | 118.37K | |
| Q1 2022 | share | 0.00% | 0 shares | -824K | $14.19 | 118.37K | |
| Q4 2021 | share | 0.00% | 0 shares | -142K | $21.42 | 118.37K | |
| Q3 2021 | share | 0.00% | 0 shares | -291K | $22.35 | 118.37K | |
| Q2 2021 | share | 0.00% | 0 shares | -497K | $24.81 | 118.37K | |
| Q1 2021 | share | 0.00% | 0 shares | 380K | $29.01 | 118.37K | |
| Q4 2020 | share | Decrease | -10.18% | -13.41K shares | -1.00M | $25.8 | 118.37K |
| Q3 2020 | share | Increase | 0.00% | 131.78K shares | 4.05M | $30.79 | 131.78K |